Indaptus Therapeutics INDP
NASDAQ INDP
$1.25 -0.13 (-9.29%)
As of: Aug 21, 2026 · 3:27 PM EDT

Indaptus Therapeutics (INDP) EPS (Basic) Growth (5y) (2025 - 2026)

Indaptus Therapeutics (INDP) EPS (Basic) Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.83 Bn 130.98 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.79 Bn 77.79 Bn 3.93 Bn
3 Argenx Se 64.95 Bn 59.77 Bn 1.37 Bn
4 Moderna 58.59 Bn 53.46 Bn 52.00 Mn
5 BeOne Medicines 41.93 Bn 36.83 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.52 Bn 28.21 Bn 992.69 Mn
7 BioNTech SE 27.98 Bn 9.58 Bn 668.28 Mn
8 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn -
10 Indaptus Therapeutics 145.16 Mn 133.61 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 96.16%
Mar 31, 2026 92.85%
Dec 31, 2025 5.89%
Sep 30, 2025 34.60%
Jun 30, 2025 84.48%
Mar 31, 2025 86.23%